Responses
Clinical and epidemiological research
Extended report
Positivity for anti-cyclic citrullinated peptide is associated with a better response to abatacept: data from the ‘Orencia and Rheumatoid Arthritis’ registry
Compose a Response to This Article
Other responses
No responses have been published for this article.